logo

Ritter Pharmaceuticals, Inc. (RTTR)



Trade RTTR now with
  Date
  Headline
10/31/2017 6:58:21 AM Ritter Pharmaceuticals Q3 Loss Narrows To $0.14 From $0.41 Last Year
9/29/2017 8:05:48 AM Ritter Pharma Prices $23 Mln Public Offering
8/18/2017 9:30:38 AM Ritter Announces Phase 3 Plans After Its End Of Phase 2 Meeting With FDA On RP-G28 For Lactose Intolerance
8/7/2017 6:22:55 AM Ritter Pharma Q2 Loss Per Share $0.14 Vs Loss $0.48 Last Year
8/3/2017 9:32:01 AM Ritter Reports Further Analysis From Phase 2b/3 Trial Results Demonstrating Reductions In Lactose Intolerance Symptoms
5/9/2017 7:28:33 AM Ritter Pharma Q1 Loss Per Share $0.14 Vs Loss $0.36 Last Year
2/27/2017 9:05:56 AM Ritter Pharma Q4 Loss/shr Widens To $0.74 From $0.27 Last Year
1/23/2017 9:07:14 AM Ritter Collaborates With University Of Nebraska To Explore Development Of Microbiome Therapeutics In Metabolic Syndrome
11/7/2016 8:33:56 AM Ritter Pharma Q3 Net Loss/shr $0.41 Vs. Loss/shr $0.40 Prior Year
10/26/2016 8:04:36 AM Ritter Pharma Prices $5 Mln Public Offering Of Common Stock
  
 
>